Alzheimer's disease: epidemiology.

[1]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[2]  Winnie S. Liang,et al.  GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.

[3]  A. Myers,et al.  Common genetic variation within the Low-Density Lipoprotein Receptor-Related Protein 6 and late-onset Alzheimer's disease , 2007, Proceedings of the National Academy of Sciences.

[4]  Yaakov Stern,et al.  The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. , 2007, Archives of neurology.

[5]  K. Lunetta,et al.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.

[6]  F. Panza,et al.  Lipid metabolism in cognitive decline and dementia , 2006, Brain Research Reviews.

[7]  Yaakov Stern,et al.  Mediterranean diet and risk for Alzheimer's disease , 2006, Annals of neurology.

[8]  Rivka Inzelberg,et al.  Association of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community. , 2006, American journal of human genetics.

[9]  David Loewenstein,et al.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. , 2006, Archives of general psychiatry.

[10]  J. Haines,et al.  A genome‐wide linkage analysis of dementia in the Amish , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[11]  O. Gureje,et al.  Cholesterol, APOE genotype, and Alzheimer disease , 2006, Neurology.

[12]  Eric E. Smith,et al.  Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy , 2006, Neurology.

[13]  O. Gureje,et al.  APOE ε4 is not associated with Alzheimer's disease in elderly Nigerians , 2006 .

[14]  C. Mathers,et al.  Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.

[15]  J. Hanlon,et al.  Dementia and Alzheimer's Disease in Community-Dwelling Elders Taking Vitamin C and/or Vitamin E , 2005, The Annals of pharmacotherapy.

[16]  Yaakov Stern,et al.  Cognitive Decline and Literacy Among Ethnically Diverse Elders , 2005, Journal of geriatric psychiatry and neurology.

[17]  H. Staehelin,et al.  Micronutrients and Alzheimer's disease , 2005, Proceedings of the Nutrition Society.

[18]  D. Praticò,et al.  Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti‐inflammatory drugs , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  Hilkka Soininen,et al.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. , 2005, Archives of neurology.

[20]  T. Fritsch,et al.  Participation in Novelty-Seeking Leisure Activities and Alzheimer’s Disease , 2005, Journal of geriatric psychiatry and neurology.

[21]  L S Honig,et al.  Aggregation of vascular risk factors and risk of incident Alzheimer disease , 2005, Neurology.

[22]  B. Winblad,et al.  The age-dependent relation of blood pressure to cognitive function and dementia , 2005, The Lancet Neurology.

[23]  S. DeKosky,et al.  Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease , 2005, Neurobiology of Aging.

[24]  F. Saura-calixto,et al.  Study of plasma antioxidant status in Alzheimer's disease , 2005, European journal of neurology.

[25]  Constantine Lyketsos,et al.  Dementia and Alzheimer's Disease Incidence in Relationship to Cardiovascular Disease in the Cardiovascular Health Study Cohort , 2005, Journal of the American Geriatrics Society.

[26]  S. Paul,et al.  Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease. , 2005, Endocrinology.

[27]  R. Tanzi,et al.  The genetic epidemiology of neurodegenerative disease. , 2005, The Journal of clinical investigation.

[28]  M. M. Mielke,et al.  High total cholesterol levels in late life associated with a reduced risk of dementia , 2005, Neurology.

[29]  E. Mariani,et al.  Incidence and etiology of dementia in a large elderly Italian population , 2005, Neurology.

[30]  M. Owen,et al.  Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[31]  S. DeKosky,et al.  Alzheimer disease and mortality: a 15-year epidemiological study. , 2005, Archives of neurology.

[32]  K. Blennow,et al.  The link between cholesterol and Alzheimer's disease , 2005, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[33]  A. Zonderman,et al.  Depressive symptoms, sex, and risk for Alzheimer's disease , 2005, Annals of neurology.

[34]  A. Green,et al.  Depression and the Risk of Alzheimer Disease , 2005, Epidemiology.

[35]  G. Schellenberg,et al.  Developmental and vascular risk factors for Alzheimer's disease , 2005, Neurobiology of Aging.

[36]  P. S. St George-Hyslop,et al.  Molecular biology and genetics of Alzheimer's disease. , 2005, Comptes rendus biologies.

[37]  D. Sparks,et al.  Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. , 2005, Archives of general psychiatry.

[38]  M. Daly,et al.  Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.

[39]  Rena Li,et al.  Estrogen and brain: synthesis, function and diseases. , 2005, Frontiers in bioscience : a journal and virtual library.

[40]  K. Jellinger.  Head injury and dementia , 2004, Current opinion in neurology.

[41]  E. B. Larson,et al.  Statin therapy and risk of dementia in the elderly , 2004, Neurology.

[42]  Steven J. Schrodi,et al.  Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[43]  John Q. Trojanowski,et al.  Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury , 2004, Experimental Neurology.

[44]  R. Maccioni,et al.  Biological Markers of Alzheimers Disease and Mild Cognitive Impairment , 2004 .

[45]  R. Mayeux,et al.  Hyperinsulinemia and risk of Alzheimer disease , 2004, Neurology.

[46]  R. Nitrini,et al.  Incidence of Dementia in a Community-Dwelling Brazilian Population , 2004, Alzheimer disease and associated disorders.

[47]  Ellen M Wijsman,et al.  Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. , 2004, American journal of human genetics.

[48]  J. Vilalta-Franch,et al.  Incidence of Dementia in a Rural Community in Spain: The Girona Cohort Study , 2004, Neuroepidemiology.

[49]  M. Kamboh,et al.  Molecular Genetics of Late‐Onset Alzheimer's Disease , 2004, Annals of human genetics.

[50]  R. Mayeux,et al.  Cardiovascular risk factors and Alzheimer’s disease , 2004, Current atherosclerosis reports.

[51]  S. Henderson,et al.  High carbohydrate diets and Alzheimer's disease. , 2004, Medical hypotheses.

[52]  R. Mayeux,et al.  Alcohol Intake and Risk of Dementia , 2004, Journal of the American Geriatrics Society.

[53]  P. Eikelenboom,et al.  Neuroinflammatory perspectives on the two faces of Alzheimer’s disease , 2004, Journal of Neural Transmission.

[54]  R. Martins,et al.  Oestrogen replacement therapy may improve memory functioning in the absence of APOE e4 , 2004 .

[55]  P. Kehoe,et al.  Vascular risk and genetics of sporadic late-onset Alzheimer’s disease , 2004, Journal of Neural Transmission.

[56]  L. Letenneur.  Risk of dementia and alcohol and wine consumption: a review of recent results. , 2004, Biological research.

[57]  Deborah Gustafson,et al.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. , 2004, Archives of neurology.

[58]  Eden R Martin,et al.  Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. , 2003, Human molecular genetics.

[59]  R. Mayeux,et al.  Stroke and the risk of Alzheimer disease. , 2003, Archives of neurology.

[60]  S. Younkin,et al.  Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. , 2003, Human molecular genetics.

[61]  D A Bennett,et al.  Rate of cognitive decline and mortality in Alzheimer’s disease , 2003, Neurology.

[62]  R. Mayeux,et al.  Plasma A&bgr;40 and A&bgr;42 and Alzheimer’s disease: Relation to age, mortality, and risk , 2003 .

[63]  I. Skoog,et al.  Hypertension, hypertension-clustering factors and Alzheimer's disease , 2003, Neurological research.

[64]  M. Crowe,et al.  Does participation in leisure activities lead to reduced risk of Alzheimer's disease? A prospective study of Swedish twins. , 2003, The journals of gerontology. Series B, Psychological sciences and social sciences.

[65]  L. Thal,et al.  Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology , 2003, Neurology.

[66]  Deborah Gustafson,et al.  An 18-year follow-up of overweight and risk of Alzheimer disease. , 2003, Archives of internal medicine.

[67]  J. Growdon,et al.  Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid β-Protein Levels , 2003 .

[68]  S. Asthana,et al.  Insulin increases CSF Aβ42 levels in normal older adults , 2003, Neurology.

[69]  L. Farrer,et al.  Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. , 2003, Human molecular genetics.

[70]  R. Mayeux,et al.  Antioxidant vitamin intake and risk of Alzheimer disease. , 2003, Archives of neurology.

[71]  S. Craft,et al.  The Role of Insulin Resistance in the Pathogenesis of Alzheimer’s Disease , 2003, CNS drugs.

[72]  M. Albert,et al.  Results of a high-resolution genome screen of 437 Alzheimer's disease families. , 2003, Human molecular genetics.

[73]  M. Combrinck,et al.  Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method. , 2003, European journal of endocrinology.

[74]  Takashi Morihara,et al.  Selective inhibition of Aβ42 production by NSAID R‐enantiomers , 2002 .

[75]  R. Hébert,et al.  Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. , 2002, American journal of epidemiology.

[76]  Z. Makita,et al.  Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques. , 2002, Neuroscience Letters.

[77]  R. Mayeux,et al.  The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function , 2002, Neurology.

[78]  M. Owen,et al.  Full genome screen for Alzheimer disease: stage II analysis. , 2002, American journal of medical genetics.

[79]  Y. Stern,et al.  Influence of leisure activity on the incidence of Alzheimer’s Disease , 2001, Neurology.

[80]  D. Easton,et al.  Genome-wide linkage disequilibrium mapping of late-onset Alzheimer’s disease in Finland , 2001, Neurology.

[81]  D Commenges,et al.  Mortality with dementia: results from a French prospective community-based cohort. , 2001, American journal of epidemiology.

[82]  D. Bennett,et al.  Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. , 2001, Archives of neurology.

[83]  J. H. Lee,et al.  Specificity of the fivefold increase in AD in mothers of adults with Down syndrome , 2001, Neurology.

[84]  S. DeKosky,et al.  Incidence of Alzheimer’s disease in a rural community in India , 2001, Neurology.

[85]  You-Qiang Song,et al.  Screening for PS1 mutations in a referral-based series of AD cases , 2001, Neurology.

[86]  Monique M. B. Breteler,et al.  Incidence of dementia: does gender make a difference? , 2001, Neurobiology of Aging.

[87]  J. Thornby,et al.  Longitudinal follow‐up of depressive symptoms among normal versus cognitively impaired elderly , 2001, International journal of geriatric psychiatry.

[88]  H. Soininen,et al.  Midlife vascular risk factors and late-life mild cognitive impairment , 2001, Neurology.

[89]  T Ostbye,et al.  A reevaluation of the duration of survival after the onset of dementia. , 2001, The New England journal of medicine.

[90]  C. Bergmann,et al.  Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[91]  B. Tycko,et al.  Elevated plasma amyloid β-peptide 1–42 and onset of dementia in adults with Down syndrome , 2001, Neuroscience Letters.

[92]  H. Morita,et al.  Plasma levels of amyloid β proteins did not differ between subjects taking statins and those not taking statins , 2001, Annals of neurology.

[93]  V. Mor,et al.  Gender differences in predictors of mortality in nursing home residents with AD , 2001, Neurology.

[94]  Robert P. Friedland,et al.  Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[95]  J. Lindsay,et al.  Physical activity and risk of cognitive impairment and dementia in elderly persons. , 2001, Archives of neurology.

[96]  A Ogunniyi,et al.  Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. , 2001, JAMA.

[97]  R. Costa,et al.  Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan , 2001, Neurology.

[98]  F. Huppert,et al.  Incidence and course of dementia in people with Down's syndrome: findings from a population-based study. , 2001, Journal of intellectual disability research : JIDR.

[99]  M. Owen,et al.  Susceptibility locus for Alzheimer's disease on chromosome 10. , 2000, Science.

[100]  J. Blangero,et al.  Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. , 2000, Science.

[101]  M G McInnis,et al.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.

[102]  Y. Ihara,et al.  Effect of Apolipoprotein E Allele ε4 on the Initial Phase of Amyloid β-Protein Accumulation in the Human Brain , 2000 .

[103]  P. M. Conneally,et al.  Identification of Novel Genes in Late-Onset Alzheimer's Disease , 2000, Experimental Gerontology.

[104]  H Jick,et al.  Statins and the risk of dementia , 2000, The Lancet.

[105]  J. Guralnik,et al.  Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias , 2000, Neurology.

[106]  G. Celesia,et al.  Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.

[107]  O. Gureje,et al.  Epidemiology of dementia in Nigeria: results from the Indianapolis–Ibadan study , 2000, European journal of neurology.

[108]  D. Kovacs.  α2-Macroglobulin in late-onset Alzheimer's disease , 2000, Experimental Gerontology.

[109]  R Doll,et al.  Smoking and dementia in male British doctors: prospective study , 2000, BMJ : British Medical Journal.

[110]  C. DeCarli,et al.  Head injury and the risk of AD in the MIRAGE study , 2000, Neurology.

[111]  S. DeKosky,et al.  Ten-year incidence of dementia in a rural elderly US community population , 2000, Neurology.

[112]  M. Breteler,et al.  Vascular risk factors for Alzheimer’s disease: An epidemiologic perspective , 2000, Neurobiology of Aging.

[113]  J. Haines,et al.  Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. , 2000, American journal of human genetics.

[114]  R. Havlik,et al.  Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.

[115]  P. George-Hyslop.  Molecular genetics of Alzheimer’s disease , 2000, Biological Psychiatry.

[116]  A Hofman,et al.  Prognosis with stroke in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[117]  E M Wijsman,et al.  The number of trait loci in late-onset Alzheimer disease. , 2000, American journal of human genetics.

[118]  V. Hachinski,et al.  Educational attainment and socioeconomic status of patients with autopsy-confirmed Alzheimer disease. , 2000, Archives of neurology.

[119]  A Hofman,et al.  Prognosis with dementia in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[120]  A Hofman,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[121]  A. Hofman,et al.  Head trauma and risk of dementia and Alzheimer’s disease , 1999, Neurology.

[122]  H. Wiśniewski,et al.  Plasma amyloid β‐peptide 1–42 and incipient Alzheimer's disease , 1999 .

[123]  B. Winblad,et al.  Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. , 1999, Journal of clinical epidemiology.

[124]  Truls Østbye,et al.  Mortality in elderly Canadians with and without dementia , 1999, Neurology.

[125]  K. Hall,et al.  Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. , 1999, American journal of epidemiology.

[126]  R. Mayeux,et al.  Rates of dementia in three ethnoracial groups , 1999, International journal of geriatric psychiatry.

[127]  R. Mayeux,et al.  The influence of smoking on the risk of Alzheimer’s disease , 1999, Neurology.

[128]  J. Haines,et al.  Further evidence linking late-onset Alzheimer disease with chromosome 12. , 1999, JAMA.

[129]  K. Andersen,et al.  Incidence of very mild to severe dementia and Alzheimer’s disease in Denmark , 1999, Neurology.

[130]  E. Kokmen,et al.  Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study. , 1999, American journal of epidemiology.

[131]  S. Xiao,et al.  A preliminary analysis of incidence of dementia in Shanghai, China , 1998, Psychiatry and clinical neurosciences.

[132]  E. Khedr,et al.  Prevalence of Alzheimer’s Disease and Other Dementing Disorders: Assiut-Upper Egypt Study , 1998, Dementia and Geriatric Cognitive Disorders.

[133]  S. DeKosky,et al.  Prevalence of Alzheimer's disease and other dementias in rural India , 1998, Neurology.

[134]  L. Beckett,et al.  Vitamin E and Vitamin C Supplement Use and Risk of Incident Alzheimer Disease , 1998, Alzheimer disease and associated disorders.

[135]  M. Owen,et al.  Genetic studies on chromosome 12 in late-onset Alzheimer disease. , 1998, JAMA.

[136]  Steven M. Horvath,et al.  Alpha-2 macroglobulin is genetically associated with Alzheimer disease , 1998, Nature Genetics.

[137]  C. Brayne,et al.  Incidence of dementia and cognitive decline in over-75s in Cambridge: overview of cohort study , 1998, Social Psychiatry and Psychiatric Epidemiology.

[138]  E. Kokmen,et al.  Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. , 1998, American journal of epidemiology.

[139]  A. Hofman,et al.  Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.

[140]  F. Huppert,et al.  Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome , 1998, British Journal of Psychiatry.

[141]  L. Amaducci,et al.  Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging , 1998, Neurology.

[142]  K. Marder,et al.  The APOE- (cid:101) 4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and Hispanics , 2001 .

[143]  K. Yaffe,et al.  Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. , 1998, JAMA.

[144]  J. Haines,et al.  No genetic association between the LRP receptor and sporadic or late-onset familial Alzheimer disease , 1998, Neurogenetics.

[145]  J. Haines,et al.  Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. , 1997, JAMA.

[146]  A. Goate,et al.  Molecular genetics of Alzheimer’s disease , 2004, Current psychiatry reports.

[147]  R. Doody,et al.  Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees , 1997, Neurology.

[148]  D. Commenges,et al.  Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. , 1997, Revue neurologique.

[149]  W F Stewart,et al.  Risk of Alzheimer's disease and duration of NSAID use , 1997, Neurology.

[150]  K. Marder,et al.  Alzheimer's disease after remote head injury: an incidence study. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[151]  A. Hofman,et al.  Non-insulin-dependent Diabetes Mellitus (niddm) Association of Diabetes Mellitus and Dementia: the Rotterdam Study , 2022 .

[152]  D J Foley,et al.  Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. , 1996, JAMA.

[153]  Yaakov Stern,et al.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease , 1996, The Lancet.

[154]  R. Mayeux,et al.  Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. , 1996, Archives of general psychiatry.

[155]  R. Havlik,et al.  The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.

[156]  H C Hendrie,et al.  Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. , 1995, The American journal of psychiatry.

[157]  R. Brookmeyer,et al.  Sources of variability in prevalence rates of Alzheimer's disease. , 1995, International journal of epidemiology.

[158]  Eric B. Larson,et al.  History of Depression as a Risk Factor for Alzheimer's Disease , 1995, Epidemiology.

[159]  Hiromitsu Iwamoto,et al.  Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population , 1995, Neurology.

[160]  Diederick E Grobbee,et al.  Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study , 1995, BMJ.

[161]  B. Tycko,et al.  Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease , 1995, Neurology.

[162]  B. Tycko,et al.  Apolipoprotein E and alzheimer's disease: Ethnic variation in genotypic risks , 1995, Annals of neurology.

[163]  J. Thornby,et al.  Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular types. , 1995, Dementia.

[164]  D Commenges,et al.  Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. , 1994, International journal of epidemiology.

[165]  R. Mayeux,et al.  Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome , 1994, The Lancet.

[166]  R. Mayeux,et al.  Influence of education and occupation on the incidence of Alzheimer's disease. , 1994, JAMA.

[167]  K. Morgan,et al.  Incidence of Dementia in a Representative British Sample , 1993, British Journal of Psychiatry.

[168]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[169]  Yaakov Stern,et al.  Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community‐dwelling elderly persons and their first‐degree relatives , 1993, Annals of neurology.

[170]  A. Hofman,et al.  Epidemiology of Alzheimer's disease. , 1992, Epidemiologic reviews.

[171]  A. Hofman,et al.  The prevalence of vascular dementia in europe: Facts and fragments from 1980–1990 studies , 1991, Annals of neurology.

[172]  A. Hofman,et al.  Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980–1990 prevalence findings , 1991, Annals of neurology.

[173]  A. Hofman,et al.  Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. , 1991, International journal of epidemiology.

[174]  D. Salmon,et al.  The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education , 1990, Annals of neurology.

[175]  D. Evans,et al.  Estimated prevalence of Alzheimer's disease in the United States. , 1990, The Milbank quarterly.

[176]  M. Albert,et al.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.

[177]  R. Katzman.,et al.  Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. , 1976, Archives of neurology.